THERAVET (EPA:ALVET) | WebDisclosure

Basculer en Français

8295	Companies
114809	Keywords
55260	Articles
62422	Press releases

Home
Companies
THERAVET

BRIEF

published on 09/30/2024 at 07:35, 1 month 21 days ago

TheraVet annonce une réorientation stratégique vers la fibrose pulmonaire idiopathique

Restructuration Phase II TheraVet H4Orphan Fibrose Pulmonaire
BRIEF

published on 09/30/2024 at 07:35, 1 month 21 days ago

TheraVet Announces Strategic Shift to Idiopathic Pulmonary Fibrosis

Restructuring Phase II TheraVet H4Orphan Pulmonary Fibrosis
PRESS RELEASE

published on 09/30/2024 at 07:30, 1 month 21 days ago

Informations privilégiées / Opérations de l'émetteur (acquisitions, cessions...)
TheraVet annonce un projet de transformation stratégique avec H4Orphan pour devenir leader de la fibrose pulmonaire idiopathique et développer un traitement innovant, accélérant les études cliniques en Belgique

Transformation Stratégique Étude Clinique TheraVet H4Orphan Fibrose Pulmonaire
PRESS RELEASE

published on 09/30/2024 at 07:30, 1 month 21 days ago

Inside Information / Operations of the issuer (acquisitions, sales...)
TheraVet and H4Orphan collaborate on a strategic project to create a leader in idiopathic pulmonary fibrosis, focusing on innovative treatments. Shareholders to vote on Operation in October 2024

Shareholders Vote Strategic Project TheraVet H4Orphan Idiopathic Pulmonary Fibrosis
PRESS RELEASE

published on 09/12/2024 at 07:30, 2 months 9 days ago

Rapports financiers et d'audit semestriels/examens réduits / Rapport financier semestriel
PRESS RELEASE

published on 09/12/2024 at 07:30, 2 months 9 days ago

Inside Information / Other news releases
TheraVet announces 2024 half-year results with positive sales growth and reduced operating loss. Company focuses on refinancing options and operational milestones

Sales Growth Refinancing Operating Loss 2024 Half-year Results TheraVet
PRESS RELEASE

published on 09/12/2024 at 07:30, 2 months 9 days ago

Informations privilégiées / Autres communiqués
TheraVet publie ses résultats financiers semestriels 2024 avec augmentation des ventes et réduction de la perte opérationnelle, concentrant efforts sur refinancement. Résultat net en baisse mais trésorerie assure opérations jusqu'en novembre 2024

Résultats Financiers Trésorerie Ventes Réduction TheraVet

Accesswire

Published on 11/21/2024 at 09:00, 47 minutes ago

ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 9 hours 12 minutes ago

Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 9 hours 22 minutes ago

Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies
Published on 11/21/2024 at 00:00, 9 hours 47 minutes ago

Swiss Mining Institute Conference Presentation
Published on 11/20/2024 at 23:00, 10 hours 47 minutes ago

Rektron Group Inc. Announces Appointment of a New Director and Provides Corporate Updates

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 09:01, 45 minutes ago

Original-Research: Netfonds AG (von NuWays AG): Buy
Published on 11/21/2024 at 08:59, 47 minutes ago

Black Friday Savings: Kling AI Offers 50% Off and Free Feature Upgrades
Published on 11/21/2024 at 08:59, 47 minutes ago

Économies Black Friday : Kling AI propose 50 % de réduction et des mises à niveau gratuites des fonctionnalités
Published on 11/21/2024 at 08:15, 1 hour 31 minutes ago

EBIT increases to EUR 55.6 million. Equity (net asset value) increases by EUR 49.3 million to EUR 300.3 million, which corresponds to 70.14 euros per share. The equity ratio rises to 94.85%.
Published on 11/21/2024 at 08:09, 1 hour 37 minutes ago

KAP HOLDS ITS GROUND IN A DIFFICULT INDUSTRY ENVIRONMENT IN THE FIRST NINE MONTHS OF 2024

Les Echos

Published on 11/21/2024 at 06:58, 2 hours 49 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 2 hours 49 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 2 hours 49 minutes ago

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 13 hours 39 minutes ago

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 14 hours 26 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

View all LES ECHOS COMFI WIRE